These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28838462)
1. Drug-Eluting Balloons-A New Tool in the Treatment of Cardiac Allograft Vasculopathy: A Case Series. Skoric B; Bulum J; Cikes M; Jurin H; Lovric D; Ljubas-Macek J; Samardzic J; Pasalic M; Milicic D Transplant Proc; 2017 Sep; 49(7):1675-1677. PubMed ID: 28838462 [TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience. Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510 [TBL] [Abstract][Full Text] [Related]
3. A Case Report of Drug-Eluting Balloon as a New Treatment Option for Cardiac Allograft Vasculopathy. Gulin D; Galic E; Sikic J Prog Transplant; 2018 Jun; 28(2):189-190. PubMed ID: 29595082 [No Abstract] [Full Text] [Related]
4. Percutaneous coronary interventions in cardiac allograft vasculopathy: a single-center experience. Colombo P; Bruschi G; Sacco A; Oreglia J; De Marco F; Colombo T; Botta L; Macera F; Turazza F; Frigerio M; Martinelli L; Klugmann S Transplant Proc; 2010 May; 42(4):1286-90. PubMed ID: 20534283 [TBL] [Abstract][Full Text] [Related]
5. Robotic Coronary Artery Bypass Grafting for Transplant Vasculopathy. Torregrossa G; Bravo M; Mancini D; Puskas J Ann Thorac Surg; 2019 Aug; 108(2):e77-e79. PubMed ID: 30710522 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience. Aranda JM; Pauly DF; Kerensky RA; Cleeton TS; Walker TC; Schofield RS; Leach D; Lin L; Monroe V; Calderon RE; Hill JA J Heart Lung Transplant; 2002 Aug; 21(8):860-6. PubMed ID: 12163085 [TBL] [Abstract][Full Text] [Related]
7. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy. Lee MS; Kobashigawa J; Tobis J JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388 [TBL] [Abstract][Full Text] [Related]
8. Drug eluting or bare metal stents in cardiac allograft vasculopathy: the role of oral sirolimus. Mieres J; Fernandez-Pereira C; Rodriguez-Granillo AM; Rodriguez AE Catheter Cardiovasc Interv; 2012 Feb; 79(3):496; author reply 497. PubMed ID: 21805610 [No Abstract] [Full Text] [Related]
9. Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy. Alam M; Shahzad SA; Akhtar A; Huang HD; Rogers PA; Ramanathan KB; Kleiman NS; Jneid H Int J Cardiol; 2012 Apr; 156(1):101-4. PubMed ID: 22265322 [No Abstract] [Full Text] [Related]
10. Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature. Dasari TW; Hennebry TA; Hanna EB; Saucedo JF Catheter Cardiovasc Interv; 2011 Jun; 77(7):962-9. PubMed ID: 21413135 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry. Dasari TW; Saucedo JF; Krim S; Alkhouli M; Fonarow GC; Alvarez R; Ibrahim H; Dai D; Wang TY; Costa M; Lindenfeld J; Messenger JC Am Heart J; 2015 Dec; 170(6):1086-91. PubMed ID: 26678629 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Heart Transplant Recipients With Transplant Coronary Arterial Vasculopathy. Kuroda K; Sunami H; Matsumoto Y; Nakajima S; Sato T; Seguchi O; Hata H; Yanase M; Fujita T; Kobayashi J; Fukushima N Transplant Proc; 2017; 49(1):130-134. PubMed ID: 28104120 [TBL] [Abstract][Full Text] [Related]
13. Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients. Sanidas EA; Maehara A; Mintz GS; Kubo T; Gupta A; Apfelbaum MA; Hakim D; Moses JW; Mancini DM; Rabbani LE Catheter Cardiovasc Interv; 2013 Feb; 81(3):429-35. PubMed ID: 22461357 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy. Reddy PR; Gulati A; Steen L; Sinacore J; Leya F; Heroux A J Heart Lung Transplant; 2008 Nov; 27(11):1222-8. PubMed ID: 18971095 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation. Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643 [TBL] [Abstract][Full Text] [Related]